Repository logo
Log in(current)
Repository logoMIT Open ScholarshipDSpace@MIT
  1. Home
  2. MIT Open Access Articles
  3. MIT Open Access Articles
  4. Multilayer Films Assembled from Naturally-Derived Materials for Controlled Protein Release

Multilayer Films Assembled from Naturally-Derived Materials for Controlled Protein Release

Thumbnail Image
Download
Name

Hammond_Multilayer films.pdf

Size

1.64 MB

Format

Adobe PDF

Checksum (MD5)

a87e5f6489f1bf3c4334f98803cf4415

Author(s)
Veselinovic, Jovana
•
O’Neill, Nicholas
•
Holler, Eggehard
•
Ljubimova, Julia Y.
•
Hammond, Paula T.
•
Hsu, Bryan Boen
•
Hagerman, Samantha R.
•
Jamieson, Kelsey S.
Date Issued
May 2014
Journal
Biomacromolecules
Publisher
American Chemical Society (ACS)
Citation
Hsu, Bryan B., Samantha R Hagerman, Kelsey Jamieson, Jovana Veselinovic, Nicholas O’Neill, Eggehard Holler, Julia Y. Ljubimova, and Paula T. Hammond. “Multilayer Films Assembled from Naturally-Derived Materials for Controlled Protein Release.” Biomacromolecules 15, no. 6 (June 9, 2014): 2049–2057.
Version
Author's final manuscript
Abstract
Herein we designed and characterized films composed of naturally derived materials for controlled release of proteins. Traditional drug delivery strategies rely on synthetic or semisynthetic materials or utilize potentially denaturing assembly conditions that are not optimal for sensitive biologics. Layer-by-layer (LbL) assembly of films uses benign conditions and can generate films with various release mechanisms including hydrolysis-facilitated degradation. These use components such as synthetic polycations that degrade into non-natural products. Herein we report the use of a naturally derived, biocompatible and degradable polyanion, poly(β-l-malic acid), alone and in combination with chitosan in an LbL film, whose degradation products of malic acid and chitosan are both generally recognized as safe (GRAS) by the FDA. We have found that films based on this polyanion have shown sustained release of a model protein, lysozyme that can be timed from tens of minutes to multiple days through different film architectures. We also report the incorporation and release of a clinically used biologic, basic fibroblast growth factor (bFGF), which demonstrates the use of this strategy as a platform for controlled release of various biologics.
MIT Department
Massachusetts Institute of Technology. Institute for Soldier Nanotechnologies
Massachusetts Institute of Technology. Department of Chemical Engineering
Massachusetts Institute of Technology. Department of Chemistry
Terms of Use
Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.
Persistent DSpace Link
http://hdl.handle.net/1721.1/101181
DOI of Published Version
https://doi.org/10.1021/bm5001839
Repository logo
PrivacyPermissionsAccessibilityContact us
Repository logo
Notify us about copyright concerns.